Normal view MARC view ISBD view

Influence Of Varying Levels Of Protein And Energy On The Performnace Of Japanese Quails

By: Dr . Aamir Mahmood, Rana | Dr . Jaweed Ahmad Qureshi.
Contributor(s): Dr . Muhammad | Dr . Talat Naseer Pasha.
Material type: materialTypeLabelBookPublisher: 1998Subject(s): Department of Animal NutritionDDC classification: 0690,T Dissertation note: The project was designed to find out the efficacy of ivermectin and Coumaphos against ectoparasites in cattle and buffaloes. Thirty buffaloes infested for ectoparasites were selected for the treatn,ent trials and divided into three groups i.e. Bi, B2 and B3 having ten animals in each group and thirty cattle infested for ectoparasites were selected for the treatment trials and also were divided into Cl, C2 and C3 groups. The comparative acaricidal drug trials were conducted on 20 infested animals against ectoparasites of group Bi and Cl having ten animal in each were medicated with Ivermectin (Ivomec: MSD) injected once by s/c route at dose rate of 200 pg/kg body weight. Observation were made on 7th and 14th day post-medication. Skin scrapping examination was done. The overall efficacy of invermectin on 7th and 14th day in buffaloes was 40% and 80% and in cattle 50% and 90% respectively. The comparative acaricidal drug trials were conducted on 20 infested animals for ectoparasites of B2 and C2 having ten animals in each were treated with Coumaphos (Asuntol: Bayer) at the dose rate of 30-50 gm/animal. On the 7th and 14th day post medication skin scraping examination was done. The efficacy of Coumaphos on 7th and 14th day in buffaloes was 50%, 50% and in cattle 70%, 70% respectively. Animals were also observed for any side effect of both medicine. No side effects were observed during the period from treatment to last observation in any group i.e. groups Bi, Cl and B2, C2 groups. On last observation no spontaneous recovery was noted. In B3 and C3 in untreated and control groups. From the results of present study it is concluded that lvermectin (Ivomec MSD) is the drug of choice for the treatment of ectoparasites in cattle and buffaloes when it is given at the dose rate of 0.2 mg/kg body weight by subcutaneous injection.
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)

The project was designed to find out the efficacy of ivermectin and Coumaphos against ectoparasites in cattle and buffaloes. Thirty buffaloes infested for ectoparasites were selected for the treatn,ent trials and divided into three groups i.e. Bi, B2 and B3 having ten animals in each group and thirty cattle infested for ectoparasites were selected for the treatment trials and also were divided into Cl, C2 and C3 groups.

The comparative acaricidal drug trials were conducted on 20 infested animals against ectoparasites of group Bi and Cl having ten animal in each were medicated with Ivermectin (Ivomec: MSD) injected once by s/c route at dose rate of 200 pg/kg body weight. Observation were made on 7th and 14th day post-medication. Skin scrapping examination was done. The overall efficacy of invermectin on 7th and 14th day in buffaloes was 40% and 80% and in cattle 50% and 90% respectively.

The comparative acaricidal drug trials were conducted on 20 infested animals for ectoparasites of B2 and C2 having ten animals in each were treated with Coumaphos (Asuntol: Bayer) at the dose rate of 30-50 gm/animal. On the 7th and 14th day post medication skin scraping examination was done. The efficacy of Coumaphos on 7th and 14th day in buffaloes was 50%, 50% and in cattle 70%, 70% respectively.

Animals were also observed for any side effect of both medicine. No side effects were observed during the period from treatment to last observation in any group i.e. groups Bi, Cl and B2, C2 groups. On last observation no spontaneous recovery was noted. In B3 and C3 in untreated and control groups.

From the results of present study it is concluded that lvermectin (Ivomec MSD) is the drug of choice for the treatment of ectoparasites in cattle and buffaloes when it is given at the dose rate of 0.2 mg/kg body weight by subcutaneous injection.

There are no comments for this item.

Log in to your account to post a comment.


Implemented and Maintained by UVAS Library.
For any Suggestions/Query Contact to library or Email:rehana.kousar@uvas.edu.pk Phone:+91 99239068
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.